drugset / Trial / NCT07090330
ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double-blinded, placebo-controlled, proof-of-concept study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis.
Timeline
- Start
- 2025-07-18
- Primary completion
- 2026-03-25
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORKA-001 | Unknown | — | Subcutaneous |